Reuters Pharma USA 2023 - Day 2

Market Access
Reuters Pharma USA 2023 - Day 2

Reuters Pharma USA 2023 - Day 2

We’re back in Philly for the second and final day of the Reuters Pharma USA conference. Once again, we’ll be dipping in and out of the various tracks to deliver you a little bit of everything. Highlights include a session going over payer survey results about the inflation reduction act, a session on TikTok led by two Novartis executives, and a stacked panel on real-world evidence featuring reps from Janssen, Bayer, Abbvie, Johnson & Johnson, and Evidation.

We’ll wrap the day a little early (as our correspondent has a train to catch!), but not before hearing from Victor Bulto, president of Innovative Medicines at Novartis, and Arpa Gray, chief commercial officer at Moderna. Read on below for the live blog, with updates as the day progresses.